文献速递创伤与烧伤消化、代谢与肾脏急症

阿片类药物使用障碍会诊服务对住院创伤阿片类药物使用障碍患者的影响

Impact of an opioid use disorder consult service on hospitalized trauma patients with opioid use disorder.
PubMed 文献 · J Trauma Acute Care Surg · 2023-03-14
一句话结论回顾性研究显示,创伤住院阿片类药物使用障碍患者接受专科会诊后启动MOUD、带纳洛酮出院及创伤随访的几率更高,且不增加住院时间或急性医疗利用。

该回顾性图表综述纳入2020年1月至2021年12月单中心学术医院创伤科收治的113例阿片类药物使用障碍(OUD)患者,其中81例接受OUD会诊、32例未接受。会诊组启动MOUD(OR 2.09;p<0.001)、出院带纳洛酮(OR 1.89;p<0.001)、有出院后继续OUD治疗计划(OR 1.43;p<0.001)及参加创伤团队随访(OR 1.76;p=0.02)的几率均更高。两组急性医疗利用和住院时间差异无统计学意义。作者认为,成瘾会诊服务可在不增加住院时间或急性医疗利用的情况下促进循证OUD治疗和出院后创伤随访。

要点

  • 113例创伤住院OUD患者中,81例接受OUD会诊、32例未接受,会诊组启动MOUD的OR为2.09(p<0.001)。
  • 会诊组出院带纳洛酮的OR为1.89(p<0.001),有出院后继续OUD治疗计划的OR为1.43(p<0.001)。
  • 会诊组参加创伤团队预约随访的OR为1.76(p=0.02)。
  • 两组急性医疗利用和住院时间差异无统计学意义。
  • 证据等级为治疗/管理;Level IV。

适用人群与场景

  • 单中心学术医院创伤科收治、具有国际疾病分类OUD诊断的住院创伤患者,2020年1月至2021年12月,共113例。

研究设计与关键结果

  • 研究类型为回顾性图表综述,单中心,样本量113例,比较接受OUD会诊(81例)与未接受会诊(32例)的创伤住院OUD患者。
  • 会诊组更可能住院期间启动MOUD(OR 2.09;p<0.001)。
  • 会诊组更可能出院带纳洛酮(OR 1.89;p<0.001)。
  • 会诊组更可能有出院后继续OUD治疗计划(OR 1.43;p<0.001)。
  • 会诊组更可能参加创伤团队预约随访(OR 1.76;p=0.02)。
  • 两组急性医疗利用和住院时间差异无统计学意义。

证据类型、等级与局限

  • 证据类型:回顾性图表综述;证据等级:治疗/管理;Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,OUD会诊服务可通过提高启动MOUD、出院带MOUD和纳洛酮、参加创伤随访的几率而使住院创伤患者获益,且不增加住院时间或急性医疗利用。
  • 作者认为,创伤住院期间的成瘾会诊服务干预可能有助于促进循证OUD治疗和出院后创伤治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Opioid use disorder (OUD) is common in the hospitalized trauma population, being a comorbid diagnosis in approximately 1% of operative trauma cases. The impact of an addiction consult service in this population has been less well studied but may lead to increased provision of evidence-based OUD treatment and improved postdischarge outcomes.

METHODS: One hundred thirteen patients with an International Classification of Diseases diagnosis of OUD who were admitted to the trauma service at a single academic hospital between January 2020 to December 2021 were included in a retrospective chart review. Wilcoxon rank-sum tests were used to evaluate differences between patients who received an OUD consult and those who did not. Regression analysis was used to assess differences in postdischarge acute care utilization, attendance of follow-up appointments, initiation of and discharge on medication for opioid use disorder (MOUD), naloxone prescribing at discharge, and length of stay (LOS) between the consult and no-consult groups.

RESULTS: Eighty-one patients in the study population received a consult and 32 did not. Patients in the consult group were more likely to have started MOUD during their admission (odds ratio [OR], 2.09; p < 0.001), be discharged with naloxone (OR, 1.89; p < 0.001), have a plan in place for continued OUD treatment at discharge (OR, 1.43; p < 0.001), and attend scheduled follow-up appointments with the trauma team (OR, 1.76; p = 0.02). Differences in acute care utilization and LOS between the two groups were not statistically significant.

CONCLUSION: An OUD consult service can provide benefit to hospitalized trauma patients by increasing likelihood of starting MOUD, of discharging with MOUD and naloxone, and of attending trauma follow-up appointments without increasing LOS or acute care utilization. Thus, addiction consult service interventions during hospital admissions for trauma may serve to facilitate both evidence-based OUD care and posthospitalization trauma care.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Muller M, Weyer G, Zakrison T, et al. Impact of an opioid use disorder consult service on hospitalized trauma patients with opioid use disorder. J Trauma Acute Care Surg. 2023. PMID: 36914601. doi:10.1097/TA.0000000000003965

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。